PAGLIARULO, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 4.725
AS - Asia 1.983
EU - Europa 1.628
SA - Sud America 526
AF - Africa 66
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.933
Nazione #
US - Stati Uniti d'America 4.658
SG - Singapore 844
CN - Cina 425
BR - Brasile 409
IT - Italia 404
HK - Hong Kong 263
SE - Svezia 251
DE - Germania 218
RU - Federazione Russa 176
VN - Vietnam 133
UA - Ucraina 130
FR - Francia 126
FI - Finlandia 101
GB - Regno Unito 88
IN - India 71
AR - Argentina 33
CA - Canada 29
BD - Bangladesh 28
IL - Israele 26
ID - Indonesia 25
BE - Belgio 22
MX - Messico 20
IQ - Iraq 19
ZA - Sudafrica 19
JP - Giappone 18
PL - Polonia 18
ES - Italia 17
IE - Irlanda 17
VE - Venezuela 17
EC - Ecuador 16
PK - Pakistan 16
SA - Arabia Saudita 16
TR - Turchia 16
CO - Colombia 15
CL - Cile 14
CI - Costa d'Avorio 13
MA - Marocco 11
MY - Malesia 11
LT - Lituania 10
PH - Filippine 10
PY - Paraguay 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
AE - Emirati Arabi Uniti 8
NL - Olanda 7
TN - Tunisia 7
AT - Austria 6
AZ - Azerbaigian 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
NP - Nepal 5
PT - Portogallo 5
KG - Kirghizistan 4
LB - Libano 4
PS - Palestinian Territory 4
AL - Albania 3
AU - Australia 3
CH - Svizzera 3
DK - Danimarca 3
DZ - Algeria 3
IR - Iran 3
JO - Giordania 3
KE - Kenya 3
MK - Macedonia 3
NI - Nicaragua 3
PA - Panama 3
PE - Perù 3
RO - Romania 3
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
GR - Grecia 2
KH - Cambogia 2
KR - Corea 2
KW - Kuwait 2
OM - Oman 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LV - Lettonia 1
MM - Myanmar 1
MR - Mauritania 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
Totale 8.931
Città #
Fairfield 461
Ashburn 437
Singapore 422
Woodbridge 397
Chandler 331
Jacksonville 303
Houston 293
San Jose 264
Hong Kong 263
Seattle 200
Nyköping 187
Ann Arbor 177
Cambridge 161
Wilmington 161
Beijing 115
Roxbury 75
Lauterbourg 74
Lawrence 73
Nanjing 67
Dallas 62
Inglewood 59
Los Angeles 55
Boardman 48
Des Moines 44
São Paulo 44
New York 42
Ho Chi Minh City 41
Santa Clara 32
Brooklyn 29
Buffalo 28
Hanoi 28
Helsinki 27
Council Bluffs 25
Princeton 25
Bari 23
Brussels 21
Tel Aviv 21
Hebei 18
Dublin 17
Munich 17
Nanchang 17
Tokyo 17
Warsaw 17
Changsha 16
Falkenstein 16
Jiaxing 16
Moscow 16
Frankfurt am Main 15
Atlanta 14
Rome 14
Abidjan 13
Shenyang 13
Johannesburg 12
London 12
Belo Horizonte 10
Da Nang 10
Dearborn 10
Denver 10
Milan 10
Paris 10
Tianjin 10
Baghdad 9
Boston 9
Brasília 9
Phoenix 9
Poplar 9
Tashkent 9
Toronto 9
Bologna 8
Brno 8
Chicago 8
Orem 8
Osasco 8
The Dalles 8
Caracas 7
Chennai 7
Lahore 7
Manchester 7
Mexico City 7
San Diego 7
San Francisco 7
Shanghai 7
Columbus 6
Curitiba 6
Delhi 6
Guangzhou 6
Haiphong 6
Naples 6
New Delhi 6
Ottawa 6
Rio de Janeiro 6
Riyadh 6
Stockholm 6
São Bernardo do Campo 6
Turku 6
Auburn Hills 5
Campinas 5
Chandigarh 5
Jakarta 5
Kuala Lumpur 5
Totale 5.715
Nome #
Linfadenectomia iliaco-otturatoria: quando e perchè 364
Bicalutamide failure in prostate cancer treatment: involvement of Multi Drug Resistance proteins 217
Human epididymal and prostatic tracts of vas deferens: different contraction response to noradrenaline stimulation in isolated organ bath assay 172
The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line 161
Correlation between sigma2 receptor protein expression and histopathologic grade in human bladder cancer 152
Antiproliferative activity evaluation of a series of N-1,3-benzothiazol-2-ylbenzamides as novel apoptosis inducers 152
Central nervous system metastases from castration-resistant prostate cancer in the docetaxel era. 151
Celecoxib for the treatment of non muscle invasive bladder cancer. Results from the first phase II clinical trial 148
A CONCISE 4-GENE PANEL CAN PREDICT CLINICAL OUTCOME IN URINARY BLADDER CANCER 141
Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer 133
Clinically overt venous thromboembolism after urologic cancer surgery: results from the @RISTOS Study 131
Contrast-enhanced multislice pneumo-CT-cystography in the evaluation of urinary bladder neoplasms 130
Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer 130
Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I–II study 128
Role of genetic and expression profiling in pharmacogenomics: the changing face of patient management. 125
Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer 125
A COMPARISON OF HAND-SEWN AND STA PLED W ILEAL RESERVOIR FOR ORTHOTO PIC BLADER REPLACEMENT 120
Surgical treatment of a rare case of epithelioid hemangioendothelioma of the azygos vein 119
RE-TREATMENT WITH DOCETAXEL IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER (CRPC) 114
The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer 114
Significance of occult metastases to the lymph nodes in patients with prostate cancer. Results from a long term follow up study 112
AGE AND STAGE AS PREDICTIVE FACTORS FOR A ORTHOTO PIC NEOBLADER AFTER RADICAL CYSTECTOMY: RESULTS ON 290 CASES. AGILE GROUP EXPERIENCE 112
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy. 110
Approccio multi-target alla terapia medica dell’ipertrofia prostatica benigna 108
Molecular changes of malignant mesothelioma in the testis and their impact on prognosis: Analyses of two cases 107
Celecoxib for the prevention of nonmuscle invasive bladder cancer: Results from a matched control study 106
Reply to Erik B. Cornel's Letter to the Editor re: Vincenzo Pagliarulo, Sergio Bracarda, Mario A. Eisenberger, et al. Contemporary role of androgen deprivation therapy for prostate cancer. Eur Urol 2012;61:11-25 101
Adenocarcinoma della prostate stadio pN0: ruolo delle metastasi occulte 100
“Neoplasie uroteliali della vescica.” 99
an observational prospective evaluation of 3-mm transperitoneal laparoscopic pyeloplasty. Feasibility and functional results 98
DETECTION AND CLINICAL SIGNIFICANCE OF OCCULT LYMPH NODE METASTASES AND CIRCULATING CANCER CELLS IN PATIENTS WITH INVASIVE BLADDER CANCER 98
Contemporary urologic minilaparoscopy: Indications, techniques, and surgical outcomes in a multi-institutional European cohort 96
Biopsia prostatica, quanti prelievi?: la nostra proposta 96
Botulinum Toxin-A Injection in Chronic Pelvic Pain Syndrome Treatment: A Systematic Review and Pooled Meta-Analysis 94
Laparoscopic and robotic ureteral stenosis repair: a multi-institutional experience with a long-term follow-up. 94
Ruolo dell’endoscopia a fluorescenza nei carcinomi uroteliali non muscolo-infiltranti e ad alto rischio della vescica. Studio osservazionale, prospettico, multicentrico 91
Malignant mesothelioma of the tunica-vaginalis: one case report studied by microarray-comparative hybridization (a-CGH) 91
THE INTERACTION OF CELECOXIB WITH MDR TRANSPORTERS ENHANCES THE ACTIVITY OF MITOMYCIN C IN A BLADDER CANCER CELL LINE 90
Biological screening of new 2-mercaptobenzothiazole derivatives for the treatment of prostate cancer 90
Farmacocinetica, stabilità, tollerabilità e attività della MMC somministrata tramite un nuovo dispositivo per ipertermia (UniThermia®) in pazienti “BCG failures” 89
Ruolo dell’ESWL nelle urgenze della litiasi ureterale 87
Sigma-2 receptors as potential novel biomarkers during the progression of benign prostatic hypertrophy (BPH) into prostate cancer 85
Xi Nerve-sparing Robotic Radical Perineal Prostatectomy: European Single-center Technique and Outcomes 85
The dramatic COVID 19 outbreak in Italy is responsible of a huge drop of urological surgical activity: a multicenter observational study 83
Androgen deprivation therapy for prostate cancer 83
PCR Competitiva Standardizzata per la caratterizzazione molecolare di quattro linee cellulari vescicali 82
Linfoadenectomia retroperitoneale video-laparoscopica mediante accesso transperitoneale 82
null 81
The accuracy of fluorescence cystoscopy in a cohort of patients undergoing radical cystectomy 81
null 81
Athermal versus ultrasonic nerve-sparing laparoscopic radical prostatectomy: a comparison of functional and oncological outcomes 79
Quantitative transcriptional profilino of cell survival and cell death genes in cultured bladder cancer cells 79
Generation of a concise gene panel for outcome prediction in urinary bladder cancer 78
COMBINED LIDOCAINE-PRILOCAINE CREAM AND LIDOCAINE-KETOROLAC GEL PROVIDE BETTER PAIN RELIEF THAN COMBINED LIDOCAINE-PRILOCAINE CREAM AND PERIPROSTATIC NERVE BLOCK DURING TRANSRECTAL PROSTATE BIOPSY 77
Prerectal-transperineal approach for treatment of recurrent vesico-urethral anastomotic stenosis after radical prostatectomy 74
Noninfiltrative anesthesia for transrectal prostate biopsy: a randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 73
Detection of occult lymph node metastases in locally advanced node-negative prostate cancer 73
null 72
Metastasi Occulte In Linfonodi Pelvici Di Pazienti Sottoposti A Prostatectomia Radicale. Incidenza E Significato Prognostico Dopo 11 Anni Di Follow-Up Medio 71
A multi-center retrospective study of single-port versus multi-port video-assisted thoracoscopic lobectomy and anatomic segmentectomy 71
Evaluation of sigma2 receptor expression in human invasive bladder cancer 70
Correzione laparoscopica di malformazione del giunto pielo-ureterale utilizzando strumentazione da 3mm 70
The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer 70
STAT 3 activation in human bladder cancer 68
Human epididymal and prostate tracts of vas deferens: different contraction response to noradrenaline stimulation in isolated organ bath assay 68
Diagnostic accuracy of hexaminolevulinate in a cohort of patients undergoing radical cystectomy 67
Sensitivity and reproducibility of standardized-competitive RT-PCR for transcript quantification and its comparison with real time RT-PCR 66
null 64
null 64
Intravesical electro-osmotic administration of mitomycin C 62
Molecular characterization of bladder cancer cell lines by quantitative transcript profiling using the StaRT PCR assay 62
Entry techniques in laparoscopic radical and partial nephrectomy: A multicenter international survey of contemporary practices 62
Longer operative time and hospital stay are associated with postoperative cYstectomy complications: a modified Clavien classification system analysis 61
Neoplasie uroteliali della vescica 61
null 61
Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Transperineal Prostate Biopsy: Diagnostic Accuracy from a Single Center Retrospective Study 59
Prostatectomia Radicale Videolaparoscopica mediante l’uso del dispositivo Thunderbeat® 59
Neoplasie uroteliali della vescica 59
The role of Proxelan in the treatment of chronic prostatitis. Results of a randomized trial. 59
PROCEDURE MININVASIVE PER IL TRATTAMENTO DELLA IPERTROFIA PROSTATICA BENIGNA A CONFRONTO: ENUCLEAZIONE LASER VERSUS VAPORIZZAZIONE FOTOSELETTIVA 58
Sensitivity and reproducibility of Standardized Competitive RT PCR (StaRT PCR) for transcript quantification and its comparison with Taqman Real-time RT-PCR 58
Nonmuscular Invasive Urothelial Carcinoma of the Bladder in Pediatric and Young Adult Patients: Age-related Outcomes 58
L’esame obiettivo 56
Sexual dysfunction in patients under dialytic treatment 55
Modificazioni emoreologiche nei tumori della vescica 55
Endogenous testosterone density is an independent predictor of pelvic lymph node invasion in high-risk prostate cancer: results in 201 consecutive patients treated with radical prostatectomy and extended pelvic lymph node dissection 54
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis 54
null 54
Severe systemic disease of the American Society of Anesthesiologists' (ASA) physical status system classification associated with delayed length of hospital stay in 1329 consecutive patients treated with radical prostatectomy for clinical prostate cancer 52
null 52
null 51
Prognostic role of chromogranin A expression for docetaxel response in hormone-refractory metastatic prostate cancer 50
Androgen deprivation therapy and cardiovascular risk in prostate cancer 49
Urothelial carcinoma of the prostatic urethra: Long-term follow-up study 47
Contrast-enhanced multislice pneumo-CT-cystography in the evaluation of urinary bladder neoplasms 47
Robotic “Side Hole” Technique Placement of Ureteral Stent for Ureteral Lesion 47
Ectopic adrenal tissue in the kidney: A systematic review 46
Correlation between human epidermal growth factor receptor 2 (HER2) status and central nervous system (CNS) involvement in metastatic castration-resistant prostate cancer (mCRPC) 43
The Influence of Endogenous Testosterone Density on Unfavorable Disease and Tumor Load at Final Pathology in Intermediate-Risk Prostate Cancer: Results in 338 Patients Treated with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection 37
null 37
Totale 8.858
Categoria #
all - tutte 36.556
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.556


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 0 35
2021/2022511 27 65 3 14 26 59 15 23 34 28 112 105
2022/2023898 117 87 62 82 120 119 6 115 160 9 9 12
2023/2024278 34 46 9 22 22 44 2 12 2 10 5 70
2024/20251.351 57 20 107 51 44 98 107 117 62 61 206 421
2025/20262.725 411 186 188 331 306 168 348 95 291 285 100 16
Totale 9.054